Accurate Dosimetry in 131I Radionuclide Therapy Using Patient-Specific, 3-Dimensional Methods for SPECT Reconstruction and Absorbed Dose Calculation
Yuni K. Dewaraja, PhD1,
Scott J. Wilderman, PhD1,
Michael Ljungberg, PhD2,
Kenneth F. Koral, PhD1,
Kenneth Zasadny, PhD3 and
Mark S. Kaminiski, MD4
1 Division of Nuclear Medicine, Department of Radiology, The University of Michigan Medical Center, Ann Arbor, Michigan
2 Department of Medical Radiation Physics, University of Lund, Lund, Sweden
3 Pfizer Global Research and Development, Ann Arbor, Michigan
4 Division of Hematology and Oncology, Department of Internal Medicine, The University of Michigan Medical Center, Ann Arbor, Michigan

View larger version (43K):
[in a new window]
|
FIGURE 1. Two typical slices of voxel phantom show superimposed tumors. (A) Defined activity map. (B) Defined density map. (C) SPECT image. (D) Absorbed dose-rate map.
|
|

View larger version (21K):
[in a new window]
|
FIGURE 3. Counts in target VOI plotted as function of iteration number for HE collimator (A) and UHE collimator (B).
|
|

View larger version (37K):
[in a new window]
|
FIGURE 4. One slice of RIT patient CT image, SPECT image, and corresponding dose-rate map.
|
|

View larger version (16K):
[in a new window]
|
FIGURE 5. Differential dose-volume histogram corresponding to tumor outlined in patient image of Figure 4.
|
|
Copyright © 2005 by the Society of Nuclear Medicine.